Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 5, Issue 2, 2009, Pages 106-117

  Dobrovolskaia, Marina A ^a   Patri, Anil K ^a   Zheng, Jiwen ^a   Clogston, Jeffrey D ^a   Ayub, Nader ^a   Aggarwal, Parag ^a   Neun, Barry W ^a   Hall, Jennifer B ^a   McNeil, Scott E ^a  

^a SAIC FREDERICK INC   (United States)

Author keywords

Complement; Gold colloids; Hydrodynamic size; Nanoparticles; Plasma protein binding

Indexed keywords

BINDING PROFILES; COLLOIDAL GOLD; COLLOIDAL GOLD NANOPARTICLES; COMPLEMENT; COMPLEMENT SYSTEMS; GOLD COLLOID; GOLD COLLOIDS; HUMAN BLOODS; HUMAN PLASMAS; HYDRODYNAMIC SIZE; IN-VITRO; NANOPARTICLE SIZES; PLASMA PROTEIN; PLASMA PROTEIN BINDING; PROTEIN BINDING; SIZE MEASUREMENTS; THERAPEUTIC EFFICACY;

BIOCHEMISTRY; COAGULATION; COLLOID CHEMISTRY; COLLOIDS; FLUID DYNAMICS; GOLD; HYDRODYNAMICS; NANOPARTICLES; PLASMAS; SCANNING PROBE MICROSCOPY;

PARTICLE SIZE ANALYSIS;

COLLOIDAL GOLD; GOLD NANOPARTICLE; PLASMA PROTEIN;

ARTICLE; BLOOD CLOTTING; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; CONTROLLED STUDY; HUMAN; HYDRODYNAMICS; MOLECULAR INTERACTION; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PARTICLE SIZE; PLASMA PROTEIN BINDING; SURFACE CHARGE; THROMBOCYTE AGGREGATION;

BINDING SITES; BLOOD PROTEINS; GOLD; HUMANS; METAL NANOPARTICLES; MICROSCOPY, ELECTRON; MICROSCOPY, SCANNING PROBE; PARTICLE SIZE;

EID: 67349191427     PISSN: 15499634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nano.2008.08.001     Document Type: Article

References (23)

1. Allen T.M., and Cullis P.R. Drug delivery systems: entering the mainstream. Science 303 (2004) 1818-1822
2. Paciotti G.F., Myer L., Weinreich D., Goia D., Pavel N., McLaughlin R.E., et al. Colloidal gold: a novel nanoparticle vector for tumor directed drug delivery. Drug Deliv 11 (2004) 169-183
3. Sonvico F., Mornet S., Vasseur S., Dubernet C., Jaillard D., Degrouard J., et al. Folate-conjugated iron oxide nanoparticles for solid tumor targeting as potential specific magnetic hyperthermia mediators: synthesis, physicochemical characterization, and in vitro experiments. Bioconjug Chem 16 (2005) 1181-1188
4. Moghimi S.M., Hedeman H., Muir I.S., Illum L., and Davis S.S. An investigation of the filtration capacity and the fate of large filtered sterically-stabilized microspheres in rat spleen. Biochim Biophys Acta 1157 (1993) 233-240
5. Moghimi S.M., Hunter A.C., and Murray J.C. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev 53 (2001) 283-318
6. Chithrani B.D., Ghazani A.A., and Chan W.C. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett 6 (2006) 662-668
7. Cedervall T., Lynch I., Foy M., Berggard T., Donnelly S.C., Cagney G., et al. Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. Angew Chem Int Ed Engl 46 (2007) 5754-5756
8. Cedervall T., Lynch I., Lindman S., Berggard T., Thulin E., Nilsson H., et al. Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci U S A 104 (2007) 2050-2055
9. Pergolese B., Bigotto A., Muniz-Miranda M., and Sbrana G. Gold/palladium and silver/palladium colloids as novel metallic substrates for surface-enhanced Raman scattering. Appl Spectrosc 59 (2005) 194-199
10. Pergolese B., Muniz-Miranda M., and Bigotto A. Surface enhanced Raman scattering investigation of the halide anion effect on the adsorption of 1,2,3-triazole on silver and gold colloidal nanoparticles. J Phys Chem B 109 (2005) 9665-9671
11. Powers K.W., Brown S.C., Krishna V.B., Wasdo S.C., Moudgil B.M., and Roberts S.M. Research strategies for safety evaluation of nanomaterials. Part VI. Characterization of nanoscale particles for toxicological evaluation. Toxicol Sci 90 (2006) 296-303
12. Murdock R.C., Braydich-Stolle L., Schrand A.M., Schlager J.J., and Hussain S.M. Characterization of nanomaterial dispersion in solution prior to in vitro exposure using dynamic light scattering technique. Toxicol Sci 101 (2008) 239-253
13. Kobayashi H., Kawamoto S., Jo S.K., Bryant Jr. H.L., Brechbiel M.W., and Star R.A. Macromolecular MRI contrast agents with small dendrimers: pharmacokinetic differences between sizes and cores. Bioconjug Chem 14 (2003) 388-394
14. Luck M., Schroder W., Harnisch S., Thode K., Blunk T., Paulke B.R., et al. Identification of plasma proteins facilitated by enrichment on particulate surfaces: analysis by two-dimensional electrophoresis and N-terminal microsequencing. Electrophoresis 18 (1997) 2961-2967
15. Diederichs J.E. Plasma protein adsorption patterns on liposomes: establishment of analytical procedure. Electrophoresis 17 (1996) 607-611
16. Gessner A., Lieske A., Paulke B.R., and Muller R.H. Influence of surface charge density on protein adsorption on polymeric nanoparticles: analysis by two-dimensional electrophoresis. Eur J Pharm Biopharm 54 (2002) 165-170
17. Gessner A., Lieske A., Paulke B.R., and Muller R.H. Functional groups on polystyrene model nanoparticles: influence on protein adsorption. J Biomed Mater Res A 65 (2003) 319-326
18. Gessner A., Paulke B.R., Muller R.H., and Goppert T.M. Protein rejecting properties of PEG-grafted nanoparticles: influence of PEG-chain length and surface density evaluated by two-dimensional electrophoresis and bicinchoninic acid (BCA)-proteinassay. Pharmazie 61 (2006) 293-297
19. Peracchia M.T., Harnisch S., Pinto-Alphandary H., Gulik A., Dedieu J.C., Desmaele D., et al. Visualization of in vitro protein-rejecting properties of PEGylated stealth (R) polycyanoacrylate nanoparticles. Biomaterials 20 (1999) 1269-1275
20. Gref R., Luck M., Quellec P., Marchand M., Dellacherie E., Harnisch S., et al. 'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloids Surf B Biointerfaces 18 (2000) 301-313
21. Salvador-Morales C., Flahaut E., Sim E., Sloan J., Green M.L., and Sim R.B. Complement activation and protein adsorption by carbon nanotubes. Mol Immunol 43 (2006) 193-201
22. Schaller J., Gerber S., Kampfer U., Lejon S., and Trachsel C. Human blood proteins: structure and function (2008), Wiley, New York
23. Lynch T., Cedervall M., Lundqvist C., Cabaleiro-Lago S., Linse S., and Dawson K.A. The nanoparticle-protein complex as a biological entity; a complex fluids and surface science challenge for the 21st century. Adv Colloid Interface Sci 134-135 (2007) 167-174